ZAGREB, March 22 (Hina) - The sale of the second tranche of commercial bills of Pliva, Croatia's leading pharmaceutical company, was successfully completed on Monday. The transaction was carried out by the Privredna Banka Zagreb
(PBZ), within a programme of sale of Pliva's commercial bills, worth about US$58 million, a PBZ statement said. The second tranche included commercial bills worth US $3.6 million, with a maturity date June 21, 1999. The second tranche was issued to a wider circle of investors than in the case of the first instalment, issued at the end of 1998, worth US$3.6 million. Despite the unfavourable situation in an extremely insolvent money market in Croatia, over the past three months Pliva's commercial bills have proved to be one of the absolutely safe and solvent investments, the PBZ said. The Zagreb stock exchange recently included Pliva's commercial bills into one of its quota
ZAGREB, March 22 (Hina) - The sale of the second tranche of
commercial bills of Pliva, Croatia's leading pharmaceutical
company, was successfully completed on Monday. The transaction was
carried out by the Privredna Banka Zagreb (PBZ), within a programme
of sale of Pliva's commercial bills, worth about US$58 million, a
PBZ statement said.
The second tranche included commercial bills worth US $3.6 million,
with a maturity date June 21, 1999.
The second tranche was issued to a wider circle of investors than in
the case of the first instalment, issued at the end of 1998, worth
US$3.6 million.
Despite the unfavourable situation in an extremely insolvent money
market in Croatia, over the past three months Pliva's commercial
bills have proved to be one of the absolutely safe and solvent
investments, the PBZ said.
The Zagreb stock exchange recently included Pliva's commercial
bills into one of its quotations, and the Croatian National Bank
(HNB) is accepting them as a guarantee for granting its new solvency
loan to commercial banks.
(hina) rml